Company Name or Ticker Symbol
Search for other Categories
Johnson & Johnson  (JNJ)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
Price: $124.9200 $-0.74 -0.589%
Day's High: $ 125.33 Week Perf: -0.78 %
Day's Low: $ 124.36 30 Day Perf: 2.22 %
Volume (M): 941 52 Wk High: $ 129.00
Volume (M$): $ 117,719 52 Wk Avg: $ 117.41
Open: 125.05 52 Wk Low: 107.69
  JNJ Charts & Quotes
You need to upgrade your Flash Player

 Market Capitalization (Millions $) 347,353
 Shares Outstanding (Millions) 2,781
 Employees 126,500
 Revenues (TTM) (Millions $) 71,890
 Net Income (TTM) (Millions $) 16,540
 Cash Flow (TTM) (Millions $) 5,240
 Capital Exp. (TTM) (Millions $) 3,226
Johnson & Johnson
Johnson & Johnson, is engaged in the manufacture and sale of a broad range of products in the health care field. Through over 200 operating companies, it conducts business in virtually all countries of the world. Johnson & Johnson's primary interest, both historically and currently, has been in products related to human health and well-being. Johnson & Johnson was organized in the State of New Jersey in 1887.

JNJ is expected to report next financial results on April 13, 2017.

Johnson & Johnson's Segments
 Segment    3.06 % of total Revenue
 Segment    2.82 % of total Revenue
 Segment    18.37 % of total Revenue
 Segment    3.84 % of total Revenue
 Segment    2.42 % of total Revenue
 Segment    1.8 % of total Revenue
 Segment    9.08 % of total Revenue
Total Pharmaceutical
 Segment    44.67 % of total Revenue
Med. Dev. & Diag.
 Segment    35.75 % of total Revenue
 Segment    5.48 % of total Revenue
Skin Care
 Segment    5.03 % of total Revenue
Total Consumer
 Segment    19.58 % of total Revenue
  Company Estimates  
  Revenue Outlook
Johnson & Johnson does not provide revenue guidance.

Earnings Outlook
Johnson & Johnson issued annual earnings guidance on Oct. 13, 2015

Geographic Revenue Dispersion
United States 46.79 %
Europe 25.49 %
Asia Pacific 18.08 %
Other 9.63 %

Commercial Metals Co

Strong Eps Underlines Double Digits Sales Growth

For the second quarter earnings per share more than doubled by 188.89 % to $0.26 per share, followed by Sales increase of 12.74 % to $1.15 billions, compared with the prior year period.

Caleres Inc

Loss Despite Sales Growth

Caleres Inc announced earnings per share of $-0.15 and Sales of $732.23 millions in the forth quarter, Company's slipped into loss per share, versus $0.26 eps, earned in the same quarter a year ago, although Caleres Inc saw it's Sales rise by 5.06 % in the same period.

JNJ's Valuation Current
Price to Earnings PE Ratio (TTM) 21.06
Price to Earnings PE Ratio (Expected) 20.23
Price to Sales (TTM) 4.83
Price to Sales (Expected) -
Price to Book 4.93
PEG (TTM) 2.59
JNJ's Financial Strength Current
Quick Ratio 2.01
Working Capital Ratio 3.11
Leverage Ratio (MRQ) 0.93
Total Debt to Equity 0.39
Interest Coverage (TTM) 33.45
Debt Coverage (TTM) 0.94
Per Share Current
Earnings (TTM) 5.93 $
Revenues (TTM) 25.85 $
Cash Flow (TTM) 1.88 $
Cash 15.07 $
Book Value 25.32 $
Dividend (TTM) 3.15 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
JNJ's Efficiency Current
Revenue per Employee (TTM) 568,300
Net Income per Employee (TTM) 130,751
Receivable Turnover Ratio (TTM) 6.12
Inventory Turnover Ratio (TTM) 2.6
Asset Turnover Ratio (TTM) 0.52
JNJ's Profitability Ratio Current
Gross Margin 69.44 %
Operating Margin 24.46 %
Net Margin 21.98 %
Net Cash Flow Margin 4.24 %
Effective Tax Rate (TTM) 16.48 %
Management Effectiveness Current
Return On Assets (TTM) 11.86 %
Return On Investment (TTM) 14.25 %
Return On Equity (TTM) 22.95 %
Dividend Yield 2.56 %
Payout Ratio (TTM) 53.11 %
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness

Customers Net Income fell by JNJ's customers Net margin fell to %
-72.19 % 0.92 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers
You need to upgrade your Flash Player

You need to upgrade your Flash Player

You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
LLY        0.09% 
MRK        0.22% 
PFE   -0.41%    
ALXN        0.53% 
ABT   -0.31%    
ABBV        0.38% 
• View Complete Report


Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
TAX's Profile
Stock Price
TAX's Financials
TAX's Expectations
Business Description
Charts & Quotes
TAX's News
TAX's Competitors
Customers & Markets
Economic Indicators
TAX's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com